Published in J Bone Miner Res on May 31, 2005
Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors. BMC Cancer (2009) 1.04
Calcium and bone disease. Biofactors (2011) 1.02
Calcium signalling and calcium transport in bone disease. Subcell Biochem (2007) 0.89
Electro-magnetic field promotes osteogenic differentiation of BM-hMSCs through a selective action on Ca(2+)-related mechanisms. Sci Rep (2015) 0.85
Ion channels in hematopoietic and mesenchymal stem cells. Stem Cells Int (2012) 0.84
Estrogen regulates the expression and activity of epithelial sodium channel in mouse osteoblasts. Cell Mol Biol (Noisy-le-grand) (2011) 0.81
Characterization of ionic currents in human neural stem cells. Korean J Physiol Pharmacol (2008) 0.79
Distal C terminus of CaV1.2 channels plays a crucial role in the neural differentiation of dental pulp stem cells. PLoS One (2013) 0.79
Action potentials in primary osteoblasts and in the MG-63 osteoblast-like cell line. J Bioenerg Biomembr (2011) 0.76
TLR3-/4-Priming Differentially Promotes Ca(2+) Signaling and Cytokine Expression and Ca(2+)-Dependently Augments Cytokine Release in hMSCs. Sci Rep (2016) 0.76
Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia. PLoS One (2016) 0.76
Novel regulations of MEF2-A, MEF2-D, and CACNA1S in the functional incompetence of adipose-derived mesenchymal stem cells by induced indoxyl sulfate in chronic kidney disease. Cytotechnology (2016) 0.75
Effect of free calcium ions on the proliferative activity and viability of mouse embryonic stem cells. Dokl Biol Sci (2007) 0.75
Electropermeabilization of Inner and Outer Cell Membranes with Microsecond Pulsed Electric Fields: Quantitative Study with Calcium Ions. Sci Rep (2017) 0.75
Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells (2004) 4.79
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol (2009) 2.95
A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol (2012) 2.71
Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation (2012) 2.58
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace (2009) 2.52
Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol (2008) 2.37
Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation (2005) 2.15
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation (2006) 2.00
Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J (2007) 1.90
Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation (2004) 1.77
Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts. Cardiovasc Res (2006) 1.62
Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res (2009) 1.58
Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. J Mol Cell Cardiol (2003) 1.54
Electrophysiological properties of human mesenchymal stem cells. J Physiol (2003) 1.53
Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol (2006) 1.53
Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.49
Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3. J Physiol (2005) 1.43
Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol (2005) 1.37
Adult zebrafish heart as a model for human heart? An electrophysiological study. J Mol Cell Cardiol (2009) 1.29
Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol (2009) 1.23
Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. Stem Cells Dev (2006) 1.21
Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart. Mol Pharmacol (2004) 1.21
Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J (2003) 1.21
Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol (2003) 1.20
Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs. J Physiol (2013) 1.17
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res (2002) 1.15
miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol (2011) 1.15
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J Mol Cell Cardiol (2008) 1.09
Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation (2002) 1.07
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res (2007) 1.06
Cardiac mechano-electric feedback: past, present, and prospect. Prog Biophys Mol Biol (2003) 1.06
Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays. J Thorac Cardiovasc Surg (2005) 1.05
Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol (2010) 1.05
Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart. Br J Pharmacol (2009) 1.02
Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res (2007) 1.01
Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea]. Mol Pharmacol (2006) 1.01
Recovery of microarray-quality RNA from frozen EDTA blood samples. J Pharmacol Toxicol Methods (2008) 1.00
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J (2009) 1.00
Human mesenchymal stem cell proliferation and osteogenic differentiation during long-term ex vivo cultivation is not age dependent. J Bone Miner Metab (2010) 0.99
Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. Am J Physiol Endocrinol Metab (2011) 0.98
Contribution of Ca2+ influx to carbachol-induced detrusor contraction is different in human urinary bladder compared to pig and mouse. Eur J Pharmacol (2007) 0.96
Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation. J Leukoc Biol (2004) 0.96
Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells (2012) 0.96
Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J (2009) 0.96
Tissue slices from adult mammalian hearts as a model for pharmacological drug testing. Cell Physiol Biochem (2009) 0.95
Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man. J Pharmacol Exp Ther (2008) 0.94
Tissue distribution of a human Ca v 1.2 alpha1 subunit splice variant with a 75 bp insertion. Cell Calcium (2005) 0.94
Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.94
Cholinergic and purinergic responses in isolated human detrusor in relation to age. J Urol (2005) 0.94
The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. Cardiovasc Res (2013) 0.93
Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitor. J Cardiovasc Pharmacol (2013) 0.93
Myocardial tissue slices: organotypic pseudo-2D models for cardiac research & development. Future Cardiol (2009) 0.93
Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. J Clin Invest (2014) 0.93
The impact of rapid atrial pacing on ADMA and endothelial NOS. Int J Cardiol (2010) 0.92
Influence of extracellular matrix coatings on implant stability and osseointegration: an animal study. J Biomed Mater Res B Appl Biomater (2007) 0.92
Regenerative potential of glycosaminoglycans for skin and bone. J Mol Med (Berl) (2011) 0.91
The effect of electrochemically simulated titanium cathodic corrosion products on ROS production and metabolic activity of osteoblasts and monocytes/macrophages. Biomaterials (2007) 0.90
Response of human endothelial cells to oxidative stress on Ti6Al4V alloy. Biomaterials (2006) 0.89
Biological response genes after single dose administration of interferon beta-1b to healthy male volunteers. J Neuroimmunol (2008) 0.89
5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res (2006) 0.89
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction. Br J Pharmacol (2005) 0.88
Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.88
Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70. J Bone Miner Res (2012) 0.88
Design and validation of a bioreactor for simulating the cardiac niche: a system incorporating cyclic stretch, electrical stimulation, and constant perfusion. Tissue Eng Part A (2012) 0.88
Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations. Eur J Pharmacol (2011) 0.88
A new toxin from the sea anemone Condylactis gigantea with effect on sodium channel inactivation. Toxicon (2006) 0.88
Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J (2003) 0.88
Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.87
Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. Cardiovasc Res (2005) 0.87
Impaired vascular function in small resistance arteries of LOX-1 overexpressing mice on high-fat diet. Cardiovasc Res (2009) 0.87
PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients. Br J Pharmacol (2013) 0.87
Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma. Ann Hematol (2007) 0.87
Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature. Br J Pharmacol (2011) 0.86
Differentiation of chromaffin progenitor cells to dopaminergic neurons. Cell Transplant (2012) 0.86
Beta adrenergic receptor-mediated atrial specific up-regulation of RGS5. Life Sci (2004) 0.86
Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart. Br J Pharmacol (2002) 0.85
Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin. Int J Cardiol (2009) 0.85
Interactions of collagen types I and II with chondroitin sulfates A-C and their effect on osteoblast adhesion. Biomacromolecules (2007) 0.85
Interaction between autoantibodies against the beta1-adrenoceptor and isoprenaline in enhancing L-type Ca2+ current in rat ventricular myocytes. J Mol Cell Cardiol (2006) 0.85
Cardiac tissue engineering. Transpl Immunol (2002) 0.85
Bleomycin induces IL-8 and ICAM-1 expression in microvascular pulmonary endothelial cells. Exp Toxicol Pathol (2004) 0.85
Sulfated hyaluronan containing collagen matrices enhance cell-matrix-interaction, endocytosis, and osteogenic differentiation of human mesenchymal stromal cells. J Proteome Res (2012) 0.85
Propiverine and metabolites: differences in binding to muscarinic receptors and in functional models of detrusor contraction. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.85
Silencing the cardiac potassium channel Kv4.3 by RNA interference in a CHO expression system. Biochem Biophys Res Commun (2005) 0.84
Modification of Ti6AL4V surfaces using collagen I, III, and fibronectin. II. Influence on osteoblast responses. J Biomed Mater Res A (2003) 0.84
The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.84
Sulfated hyaluronan derivatives reduce the proliferation rate of primary rat calvarial osteoblasts. Glycoconj J (2009) 0.84